These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28939533)
1. Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors. Panecka-Hofman J; Pöhner I; Spyrakis F; Zeppelin T; Di Pisa F; Dello Iacono L; Bonucci A; Quotadamo A; Venturelli A; Mangani S; Costi MP; Wade RC Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3215-3230. PubMed ID: 28939533 [TBL] [Abstract][Full Text] [Related]
2. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate. Senkovich O; Schormann N; Chattopadhyay D Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691 [TBL] [Abstract][Full Text] [Related]
3. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development. Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389 [TBL] [Abstract][Full Text] [Related]
4. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways. Hardy LW; Matthews W; Nare B; Beverley SM Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081 [TBL] [Abstract][Full Text] [Related]
5. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria. Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480 [TBL] [Abstract][Full Text] [Related]
6. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major. Nare B; Hardy LW; Beverley SM J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248 [TBL] [Abstract][Full Text] [Related]
7. Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi: prospect for chemotherapy of Chagas' disease. Senkovich O; Bhatia V; Garg N; Chattopadhyay D Antimicrob Agents Chemother; 2005 Aug; 49(8):3234-8. PubMed ID: 16048931 [TBL] [Abstract][Full Text] [Related]
8. Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti- Francesconi V; Rizzo M; Pozzi C; Tagliazucchi L; Konchie Simo CU; Saporito G; Landi G; Mangani S; Carbone A; Schenone S; Santarém N; Tavares J; Cordeiro-da-Silva A; Costi MP; Tonelli M ACS Infect Dis; 2024 Aug; 10(8):2755-2774. PubMed ID: 38953453 [TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of the bifunctional enzyme dihydrofolate reductase-thymidylate synthase from Leishmania (Viannia) and its evaluation as a drug target. Osorio E; Aguilera C; Naranjo N; Marín M; Muskus C Biomedica; 2013; 33(3):393-401. PubMed ID: 24652175 [TBL] [Abstract][Full Text] [Related]
10. Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery. das Neves GM; Kagami LP; Gonçalves IL; Eifler-Lima VL Future Med Chem; 2019 Aug; 11(16):2107-2130. PubMed ID: 31370699 [TBL] [Abstract][Full Text] [Related]
11. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum. Bhattacharya A; Leprohon P; Ouellette M PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009377. PubMed ID: 33905412 [TBL] [Abstract][Full Text] [Related]
12. Probing the structure of Leishmania donovani chagasi DHFR-TS: comparative protein modeling and protein-ligand interaction studies. Maganti L; Manoharan P; Ghoshal N J Mol Model; 2010 Sep; 16(9):1539-47. PubMed ID: 20174846 [TBL] [Abstract][Full Text] [Related]
13. Insights into antifolate resistance from malarial DHFR-TS structures. Yuvaniyama J; Chitnumsub P; Kamchonwongpaisan S; Vanichtanankul J; Sirawaraporn W; Taylor P; Walkinshaw MD; Yuthavong Y Nat Struct Biol; 2003 May; 10(5):357-65. PubMed ID: 12704428 [TBL] [Abstract][Full Text] [Related]
14. Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells. Antosiewicz A; Jarmuła A; Przybylska D; Mosieniak G; Szczepanowska J; Kowalkowska A; Rode W; Cieśla J J Biomol Struct Dyn; 2017 May; 35(7):1474-1490. PubMed ID: 27187663 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase. Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776 [TBL] [Abstract][Full Text] [Related]
18. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Nare B; Luba J; Hardy LW; Beverley S Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772 [TBL] [Abstract][Full Text] [Related]
19. Sesquiterpene Lactones with Dual Inhibitory Activity against the Possart K; Herrmann FC; Jose J; Costi MP; Schmidt TJ Molecules; 2021 Dec; 27(1):. PubMed ID: 35011381 [TBL] [Abstract][Full Text] [Related]